Annual General Meeting, Emerging Leader Award and Funding for Respiratory Therapeutics

2023 Shareholder's Annual General Meeting Recap

On March 22nd, shareholders convened to approve the board of directors who will continue to serve their two year term.

CEO Akeem Gardner presented company updates on business performance, which included traction, preclinical testing of therapeutic assets, and the company’s 2023 priorities:

• Preparing for first institutional financing round

• Increased industry engagement, 6 major conferences confirmed

• Establishing our platform at scale

• Completing pre-clinical trials, beginning human clinical trials

• Asset commercialization

Canurta Receives Funding from the Government of Canada for Respiratory Disease Therapeutics

The company has received $150,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop a proof of concept for respiratory disease therapeutics.

Canurta is positioned to address respiratory diseases with rare polyphenols by preventing viral infection and replication and treating associated implications, including inflammation.

The Peak's '2023 Class of Emerging Leaders' Recognizes CEO Akeem Gardner

"He has successfully built captivating businesses, led high-performance teams across multi-channel platforms, and strategically aligned profitability with sustainability and economic development in Ontario."

The Peak recognized up-and-coming young leaders shaping Canada's economy, culture, and society.

Cultivating Innovation in Hemp: Akeem's Interview with Ontario Centre for Innovation (OCI)

"Canurta is the perfect story of entrepreneurial hard work, collaborative efforts, trusting the science, and incredible timing."

The OCI accelerates the commercialization of Made-in-Ontario intellectual property and technologies, and is funded by the Government of Ontario.

Canurta's March Milestones: Celebrating Successes and Setting New Standards

Science

• Increased the solubility of Cannflavins by 600%

• Scaling up extraction of Cannflavins to begin bioavailability trials in near future

Bioinformatics

• Implementation of Lipinski rule of 5 filter in generation pipeline

• Identified newly published bioactivity datasets to annotate our generated novel molecules

Information Technology

• Successful proof of concept of Web3 login capability to blockchain supply chain system

• Migration from enterprise to proprietary management system

Business Development

• BioTalent Canada grant awarded for 2 additional scientist wage subsidies

• Mitacs Entrepreneur International grant awarded for business travel